Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.06 +0.72%
Revenue Growth %: -23.8%
Financial Fact:
Diluted (in Shares): -23.01M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -23.8%
Financial Fact:
Diluted (in Shares): -23.01M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $23.58 million.
Cash, cash equivalents and marketable securities was $851.5 million as of September 30, 2020.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- Progress Software completes $400M acquisition of Domo's data platform
- Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
